Two pharma companies collaborate

Richard Castledine, API development team leader at Arcinova, and Martin Wilmshurst, API development chemist at Arcinova, on site at Sterling Pharma Solutions.
Richard Castledine, API development team leader at Arcinova, and Martin Wilmshurst, API development chemist at Arcinova, on site at Sterling Pharma Solutions.

A new collaboration between two Northumberland firms in the pharmaceutical sector has been announced.

The Alnwick-based contract research and development organisation Arcinova has teamed up with Sterling Pharma Solutions in a move that will significantly enhance the two companies’ offerings to their global client bases.

Arcinova will now have access to Sterling Pharma Solutions’ scale-up and pilot plant assets at its Cramlington headquarters.

The scale-up process will be executed by trained Arcinova personnel, supported by the long-established skills, infrastructure and capacity of Sterling Pharma Solutions.

Kevin Cook, CEO at Sterling Pharma Solutions, said: “This collaboration brings together complementary capabilities to make the North East of England the right choice for pharmaceutical development, scale-up and commercial manufacture.”

Ian Shott CBE, CEO of Arcinova and investor/director at Sterling Pharma Solutions, added: “I’m delighted that Arcinova and Sterling Pharma Solutions have forged this partnership; by working in collaboration and combining expertise and specialist capabilities, we can offer an even wider ranging service to the global pharmaceutical and biotechnology communities and further strengthen the level of support we offer to our clients.”